vs
Post Holdings, Inc.（POST）とSolventum（SOLV）の財務データ比較。上の社名をクリックして会社を切り替えられます
Post Holdings, Inc.の直近四半期売上が大きい（$2.2B vs $2.0B、Solventumの約1.1倍）。Post Holdings, Inc.の純利益率が高く（4.5% vs 3.2%、差は1.3%）。Post Holdings, Inc.の前年同期比売上増加率が高い（10.1% vs -3.7%）。Post Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$119.3M vs $32.0M）。過去8四半期でPost Holdings, Inc.の売上複合成長率が高い（4.3% vs -0.4%）
Post Holdings, Inc.はアメリカの代表的な包装消費財食品メーカーで、主力事業にPost Consumer Brandsを有し、本社はミネソタ州レイクビルに所在します。同社が製造する各種食品は北米を中心に世界各国で販売され、多くの消費者に支持されています。
Solventum Corporationはアメリカ発祥のヘルスケア企業で、2024年4月1日に多岐にわたる事業を展開する世界的大手企業3Mからスピンオフして独立しました。旧3M医療部門の技術や事業資産を承継し、世界各国の顧客に医療関連の製品・サービスを提供しています。
POST vs SOLV — 直接比較
売上が大きい
POST
1.1倍大きい
$2.0B
売上成長率が高い
POST
+13.8%の差
-3.7%
純利益率が高い
POST
純利益率が1.3%高い
3.2%
フリーキャッシュフローが多い
POST
FCF $87.3M多い
$32.0M
2年売上CAGRが高い
POST
2年複合成長率
-0.4%
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $2.2B | $2.0B |
| 純利益 | $96.8M | $63.0M |
| 粗利率 | 29.4% | 51.4% |
| 営業利益率 | 11.0% | 6.3% |
| 純利益率 | 4.5% | 3.2% |
| 売上前年比 | 10.1% | -3.7% |
| 純利益前年比 | -14.6% | 103.2% |
| EPS（希薄化後） | $1.71 | $0.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上POSTSOLV
| Q4 25 | $2.2B | $2.0B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.0B | $2.2B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.1B | ||
| Q1 24 | $2.0B | $2.0B |
純利益POSTSOLV
| Q4 25 | $96.8M | $63.0M | ||
| Q3 25 | $51.0M | $1.3B | ||
| Q2 25 | $108.8M | $90.0M | ||
| Q1 25 | $62.6M | $137.0M | ||
| Q4 24 | $113.3M | $31.0M | ||
| Q3 24 | $81.6M | $122.0M | ||
| Q2 24 | $99.8M | $89.0M | ||
| Q1 24 | $97.2M | $237.0M |
粗利率POSTSOLV
| Q4 25 | 29.4% | 51.4% | ||
| Q3 25 | 26.8% | 54.2% | ||
| Q2 25 | 30.0% | 54.4% | ||
| Q1 25 | 28.0% | 53.8% | ||
| Q4 24 | 30.1% | 53.9% | ||
| Q3 24 | 28.6% | 56.0% | ||
| Q2 24 | 29.6% | 54.6% | ||
| Q1 24 | 29.0% | 58.1% |
営業利益率POSTSOLV
| Q4 25 | 11.0% | 6.3% | ||
| Q3 25 | 7.5% | 80.6% | ||
| Q2 25 | 11.8% | 9.9% | ||
| Q1 25 | 9.3% | 7.3% | ||
| Q4 24 | 10.8% | 6.6% | ||
| Q3 24 | 9.5% | 13.2% | ||
| Q2 24 | 10.4% | 11.7% | ||
| Q1 24 | 9.5% | 18.9% |
純利益率POSTSOLV
| Q4 25 | 4.5% | 3.2% | ||
| Q3 25 | 2.3% | 60.4% | ||
| Q2 25 | 5.5% | 4.2% | ||
| Q1 25 | 3.2% | 6.6% | ||
| Q4 24 | 5.7% | 1.5% | ||
| Q3 24 | 4.1% | 5.9% | ||
| Q2 24 | 5.1% | 4.3% | ||
| Q1 24 | 4.9% | 11.8% |
EPS（希薄化後）POSTSOLV
| Q4 25 | $1.71 | $0.37 | ||
| Q3 25 | $0.91 | $7.22 | ||
| Q2 25 | $1.79 | $0.51 | ||
| Q1 25 | $1.03 | $0.78 | ||
| Q4 24 | $1.78 | $0.18 | ||
| Q3 24 | $1.28 | $0.70 | ||
| Q2 24 | $1.53 | $0.51 | ||
| Q1 24 | $1.48 | $1.37 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $279.3M | $878.0M |
| 総負債低いほど良い | $7.5B | $5.0B |
| 株主資本純資産 | $3.5B | $5.0B |
| 総資産 | $13.0B | $14.3B |
| 負債/資本比率低いほどレバレッジが低い | 2.16× | 1.00× |
8四半期トレンド — 暦四半期で整列
現金・短期投資POSTSOLV
| Q4 25 | $279.3M | $878.0M | ||
| Q3 25 | $176.7M | $1.6B | ||
| Q2 25 | $1.1B | $492.0M | ||
| Q1 25 | $617.6M | $534.0M | ||
| Q4 24 | $872.9M | $762.0M | ||
| Q3 24 | $787.4M | $772.0M | ||
| Q2 24 | $333.8M | $897.0M | ||
| Q1 24 | $333.4M | $996.0M |
総負債POSTSOLV
| Q4 25 | $7.5B | $5.0B | ||
| Q3 25 | $7.4B | $5.1B | ||
| Q2 25 | $7.3B | $7.8B | ||
| Q1 25 | $6.9B | $7.9B | ||
| Q4 24 | $6.9B | $8.0B | ||
| Q3 24 | $6.8B | $8.1B | ||
| Q2 24 | $6.4B | $8.3B | ||
| Q1 24 | $6.4B | $8.3B |
株主資本POSTSOLV
| Q4 25 | $3.5B | $5.0B | ||
| Q3 25 | $3.8B | $5.0B | ||
| Q2 25 | $4.0B | $3.6B | ||
| Q1 25 | $3.8B | $3.3B | ||
| Q4 24 | $3.9B | $3.0B | ||
| Q3 24 | $4.1B | $3.2B | ||
| Q2 24 | $3.9B | $2.9B | ||
| Q1 24 | $4.0B | $3.9B |
総資産POSTSOLV
| Q4 25 | $13.0B | $14.3B | ||
| Q3 25 | $13.5B | $14.0B | ||
| Q2 25 | $13.4B | $15.1B | ||
| Q1 25 | $12.8B | $14.5B | ||
| Q4 24 | $12.8B | $14.5B | ||
| Q3 24 | $12.9B | $14.7B | ||
| Q2 24 | $12.1B | $14.6B | ||
| Q1 24 | $12.2B | $14.7B |
負債/資本比率POSTSOLV
| Q4 25 | 2.16× | 1.00× | ||
| Q3 25 | 1.98× | 1.03× | ||
| Q2 25 | 1.84× | 2.14× | ||
| Q1 25 | 1.81× | 2.43× | ||
| Q4 24 | 1.79× | 2.71× | ||
| Q3 24 | 1.67× | 2.54× | ||
| Q2 24 | 1.62× | 2.90× | ||
| Q1 24 | 1.61× | 2.16× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $235.7M | $95.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $119.3M | $32.0M |
| FCFマージンFCF / 売上 | 5.5% | 1.6% |
| 設備投資強度設備投資 / 売上 | 5.4% | 3.2% |
| キャッシュ転換率営業CF / 純利益 | 2.43× | 1.51× |
| 直近12ヶ月FCF直近4四半期 | $436.0M | $-10.0M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローPOSTSOLV
| Q4 25 | $235.7M | $95.0M | ||
| Q3 25 | $301.3M | $76.0M | ||
| Q2 25 | $225.9M | $169.0M | ||
| Q1 25 | $160.7M | $29.0M | ||
| Q4 24 | $310.4M | $219.0M | ||
| Q3 24 | $235.4M | $169.0M | ||
| Q2 24 | $272.3M | $355.0M | ||
| Q1 24 | $249.6M | $442.0M |
フリーキャッシュフローPOSTSOLV
| Q4 25 | $119.3M | $32.0M | ||
| Q3 25 | $151.6M | $-21.0M | ||
| Q2 25 | $94.9M | $59.0M | ||
| Q1 25 | $70.2M | $-80.0M | ||
| Q4 24 | $171.4M | $92.0M | ||
| Q3 24 | $96.2M | $76.0M | ||
| Q2 24 | $161.5M | $297.0M | ||
| Q1 24 | $150.9M | $340.0M |
FCFマージンPOSTSOLV
| Q4 25 | 5.5% | 1.6% | ||
| Q3 25 | 6.7% | -1.0% | ||
| Q2 25 | 4.8% | 2.7% | ||
| Q1 25 | 3.6% | -3.9% | ||
| Q4 24 | 8.7% | 4.4% | ||
| Q3 24 | 4.8% | 3.7% | ||
| Q2 24 | 8.3% | 14.3% | ||
| Q1 24 | 7.5% | 16.9% |
設備投資強度POSTSOLV
| Q4 25 | 5.4% | 3.2% | ||
| Q3 25 | 6.7% | 4.6% | ||
| Q2 25 | 6.6% | 5.1% | ||
| Q1 25 | 4.6% | 5.3% | ||
| Q4 24 | 7.0% | 6.1% | ||
| Q3 24 | 6.9% | 4.5% | ||
| Q2 24 | 5.7% | 2.8% | ||
| Q1 24 | 4.9% | 5.1% |
キャッシュ転換率POSTSOLV
| Q4 25 | 2.43× | 1.51× | ||
| Q3 25 | 5.91× | 0.06× | ||
| Q2 25 | 2.08× | 1.88× | ||
| Q1 25 | 2.57× | 0.21× | ||
| Q4 24 | 2.74× | 7.06× | ||
| Q3 24 | 2.88× | 1.39× | ||
| Q2 24 | 2.73× | 3.99× | ||
| Q1 24 | 2.57× | 1.86× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
POST
| Post Consumer Brands Segment | $1.1B | 51% |
| Pet Food | $360.4M | 17% |
| Side Dishes | $221.5M | 10% |
| Weetabix | $137.9M | 6% |
| Other | $122.1M | 6% |
| Nut Butters | $105.8M | 5% |
| Sausage | $53.1M | 2% |
| Cheeseand Dairy | $41.3M | 2% |
| Protein Based Shakes | $29.3M | 1% |
| Bell Ring | $18.1M | 1% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
